The use of Q-TOF mass spectrometry techniques in biotechnology is expected to rise even faster at a CAGR of 7.5% over the forecast period.

South Korea, Seoul, Sept. 12, 2022 (GLOBE NEWSWIRE) -- As per a new industry analysis by Fact.MR, a market research and competitive intelligence provider, the global Q-TOF mass spectrometry market is projected to expand at a CAGR of 6.5% over the forecast period (2022-2027).

A typical method for examining the biological and chemical properties of molecules is Q-TOF mass spectrometry. In the field of life sciences, Q-TOF mass spectrometers are frequently employed to describe and sequence proteins. This method discovers and quantifies important proteins implicated in disease and altered phenotypes and recognizes diagnostic biomarkers for treatment. Technological advancements in Q-TOF mass spectrometry have made it possible to quickly circulate high-resolution test results.

The market is expected to rise as a result of the development of novel Q-TOF mass spectrometry equipment. The utilization of Q-TOF mass spectrometers has improved due to constant advancements in spectrometry systems. The development of Q-TOF mass spectrometer technology and rising global concerns about food safety are two of the key factors propelling market growth.

Get Sample PDF of This Research Report with Detailed Table of Content:

https://www.factmr.com/connectus/sample?flag=S&rep_id=7696

Due to their speed and suitability for quantitative analysis, Q-TOF mass spectrometry instruments are a preferred option for chemists creating combinatorial libraries. They are widely used in medical research, forensics, food hygiene, ecological assessment, and the development of novel medications.

Key Takeaways from Market Study

• The global Q-TOF mass spectrometry market is anticipated to reach US$ 1.3 billion by 2027.

• The market in Germany is expected to increase at a CAGR of 5.5% through 2027.

• The Japan market for Q-TOF mass spectrometry is projected to expand at a CAGR of 6.5% over the forecast period.

• Demand for Q-TOF mass spectrometry in pharmaceuticals is expected to rise faster at a CAGR of 6.7% from 2022 to 2027.

“Growing usage of Q-TOF mass spectrometry techniques, particularly in biotechnology, rising demand for cutting-edge equipment, and growing emphasis on R&D in the healthcare sector are the main factors driving market expansion,” says a Fact.MR analyst

Speak to Analyst:

https://www.factmr.com/connectus/sample?flag=AE&rep_id=7696

Winning Strategy

Market participants are consistently working to improve their current products and introduce new, high-end mass spectrometer devices. To help researchers get better results, key firms are creating solutions that are simple to use and offer better results. For industry growth, major manufacturers are concentrating on strategic initiatives such as partnerships and the launch and marketing of new goods.

For instance,

• Agilent Technologies Inc. introduced upgraded mass spectrometry and automation software solutions to fulfil regulatory compliance guidelines. All of Agilent's LCMS systems now have compliance features for LC/TOF and LC/Q-TOF in MassHunter and BioConfirm, guaranteeing that they all meet the regulatory requirements of users.
  
  

Competitive Landscape

Key market players are concentrating on providing better solutions to drive their market growth. Top companies have a large global presence and a diversified and technologically advanced product line.

For instance,

• Intabio and Bruker collaborated to develop a cutting-edge interface for their UHR-QTOF mass spectrometers. Intabio will work with Bruker to develop the necessary hardware and software to link the Blaze instrument to a Bruker MS.
  

Segments of Q-TOF Mass Spectrometry Industry Research

• By Type:

  • Below 2000 FWHM

  • 2000-5000 FWHM

  • Above 5000 FWHM

• By Application:

  • Biotechnology

  • Pharmaceuticals

  • Food & Beverage Testing

  • Environmental Testing

  • Petrochemicals

  • Others

• By Region:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa
    
    

Quick Buy – Q-TOF mass spectrometry Market Research Report:

https://www.factmr.com/checkout/7696

More Valuable Insights on Offer

Fact.MR, in its new offering, presents an unbiased analysis of the global Q-TOF mass spectrometry market, presenting historical demand data (2017-2021) and forecast statistics for the period of 2022-2027.

The study divulges essential insights on the market on the basis of type (below 2000 FWHM, 2000-5000 FWHM, above 5000 FWHM) and application (biotechnology, pharmaceuticals, food & beverage testing, environmental testing, petrochemicals, others), across five major regions (North America, Europe, Asia Pacific, Latin America, and MEA).

Check out more related studies published by Fact.MR Research:

Spectrometry Market - Demand for mass spectrometry is set to increase faster at a CAGR of 7.4% over the forecast period, owing to rising demand from the pharmaceutical and biotechnology sectors.

Biotechnology & Pharmaceutical Services Outsourcing Market - The global biotechnology and pharmaceutical services outsourcing market is anticipated to hold a market value of US$ 70 Bn in 2022 and US$ 112.31 Bn by 2032. The projected growth rate is nearly 5% during the forecast period from 2022 to 2032.

Biotechnology Instruments Market - Demand for Life Science Consumables Biotechnology Instruments will continue to thrive, with a documented CAGR of 15.2% during the 2015-2021 historical period of assessment, while demand for Biotechnology Instruments in hospitals & healthcare facilities proliferated at a rate of 14.7% during the same period.

Biopharmaceuticals Packaging Market - Biopharmaceuticals are medicinal drugs that are manufactured by using biotechnology. They are mainly proteins (antibodies), nucleic acids (DNA, RNA) which are commonly used for in vivo or therapeutic purposes. Biopharmaceutical packaging plays a very important role in maintaining the product quality and characteristics of the drugs.

Brain Monitoring Devices Market - Using an intracranial pressure monitoring device, doctors can determine whether one's symptoms are being brought on by high or low cerebrospinal fluid (CSF) pressure. A tiny pressure-sensitive probe that is put through the skull during the examination directly detects the pressure within your brain.

Gastrointestinal Stents Market - The global gastrointestinal stents market is expected to increase at a CAGR of 5.5% from 2022 to 2027 and climb from a market valuation of US$ 516 million in 2022 to US$ 674.3 million by 2027.

Cerebral Angiography Market - Demand for cerebral angiography systems is anticipated to rise faster in China than the global average, at 12% CAGR through 2027. In China, the development needed for the entire treatment of cardiovascular disorders in the healthcare industry is aided by solid assistance from government institutions.

About Us: 

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner. 

Contact: 
Mahendra Singh 
US Sales Office: 
11140 Rockville Pike 
Suite 400 
Rockville, MD 20852 
Email: sales@factmr.com  
Tel: +1 (628) 251-158